Denna sida på svenska
Loading profile information...

Publications

Attenuated and vectored vaccines protect nonhuman primates against Chikungunya virus
Roques P, Ljungberg K, Kümmerer Bm, Gosse L, Dereuddre-bosquet N, Tchitchek N, et al
JCI insight 2017;2(6):e83527-

H1N1 influenza virus induces narcolepsy-like sleep disruption and targets sleep-wake regulatory neurons in mice
Tesoriero C, Codita A, Zhang Md, Cherninsky A, Karlsson H, Grassi-zucconi G, et al
Proceedings of the National Academy of Sciences of the United States of America 2016;113(3):E368-77

T- and B-cell responses to multivalent prime-boost DNA and viral vectored vaccine combinations against hepatitis C virus in non-human primates
Rollier Cs, Verschoor Ej, Verstrepen Be, Drexhage Ja, Paranhos-baccala G, Liljeström P, et al
Gene therapy 2016;23(10):753-759

A coordinated cross-disciplinary research initiative to address an increased incidence of narcolepsy following the 2009-2010 Pandemrix vaccination programme in Sweden
Feltelius N, Persson I, Ahlqvist-rastad J, Andersson M, Arnheim-dahlström L, Bergman P, et al
Journal of internal medicine 2015;278(4):335-53

Alphavirus replicon DNA expressing HIV antigens is an excellent prime for boosting with recombinant modified vaccinia Ankara (MVA) or with HIV gp140 protein antigen
Knudsen Ml, Ljungberg K, Tatoud R, Weber J, Esteban M, Liljeström P
PloS one 2015;10(2):e0117042-

Humoral responses to HIVconsv induced by heterologous vaccine modalities in rhesus macaques
Borthwick Nj, Rosario M, Schiffner T, Bowles E, Ahmed T, Liljeström P, et al
Immunity, inflammation and disease 2015;3(2):82-93

Modification of a salmonid alphavirus replicon vector for enhanced expression of heterologous antigens
Guo Tc, Johansson Dx, Liljeström P, Evensen Ø, Haugland Ø
The Journal of general virology 2015;96(Pt 3):565-70

Self-replicating alphavirus RNA vaccines
Ljungberg K, Liljeström P
Expert review of vaccines 2015;14(2):177-94

Therapeutics and vaccines against chikungunya virus
Ahola T, Couderc T, Ng Lf, Hallengärd D, Powers A, Lecuit M, et al
Vector borne and zoonotic diseases (Larchmont, N.Y.) 2015;15(4):250-7

A 6K-deletion variant of salmonid alphavirus is non-viable but can be rescued through RNA recombination
Guo Tc, Johansson Dx, Haugland Ø, Liljeström P, Evensen Ø
PloS one 2014;9(7):e100184-

A novel poxvirus-based vaccine, MVA-CHIKV, is highly immunogenic and protects mice against chikungunya infection
García-arriaza J, Cepeda V, Hallengärd D, Sorzano CÓ, Kümmerer Bm, Liljeström P, et al
Journal of virology 2014;88(6):3527-47

Intradermal electroporation of RNA
Knudsen Ml, Ljungberg K, Liljeström P, Johansson Dx
Methods in molecular biology (Clifton, N.J.) 2014;1121():147-54

Kinetic and phenotypic analysis of CD8+ T cell responses after priming with alphavirus replicons and homologous or heterologous booster immunizations
Knudsen Ml, Ljungberg K, Kakoulidou M, Kostic L, Hallengärd D, García-arriaza J, et al
Journal of virology 2014;88(21):12438-51

Novel attenuated Chikungunya vaccine candidates elicit protective immunity in C57BL/6 mice
Hallengärd D, Kakoulidou M, Lulla A, Kümmerer Bm, Johansson Dx, Mutso M, et al
Journal of virology 2014;88(5):2858-66

Prime-boost immunization strategies against Chikungunya virus
Hallengärd D, Lum Fm, Kümmerer Bm, Lulla A, Lulla V, García-arriaza J, et al
Journal of virology 2014;88(22):13333-43

The adjuvant activity of alphavirus replicons is enhanced by incorporating the microbial molecule flagellin into the replicon
Knudsen Ml, Johansson Dx, Kostic L, Nordström Ek, Tegerstedt K, Pasetto A, et al
PloS one 2013;8(6):e65964-

Virus replicon particle based Chikungunya virus neutralization assay using Gaussia luciferase as readout
Glasker S, Lulla A, Lulla V, Couderc T, Drexler Jf, Liljestrom P, et al
VIROLOGY JOURNAL 2013;:235-

De-Novo Transcriptome Sequencing of a Normalized cDNA Pool from Influenza Infected Ferrets
Camp Jv, Svensson Tl, Mcbrayer A, Jonsson Cb, Liljestrom P, Bruder Ce
PLOS ONE 2012;7(5):e37104-

Differential Impact of Interferon Regulatory Factor 7 in Initiation of the Type I Interferon Response in the Lymphocytic Choriomeningitis Virus-Infected Central Nervous System versus the Periphery
Christensen Je, Fenger C, Issazadeh-navikas S, Krug A, Liljestrom P, Goriely S, et al
JOURNAL OF VIROLOGY 2012;86(13):7384-92

Host gene expression signatures discriminate between ferrets infected with genetically similar H1N1 strains
Ljungberg K, Mcbrayer A, Camp Jv, Chu Yk, Tapp R, Noah Dl, et al
PloS one 2012;7(7):e40743-

Intradermal Electroporation of Naked Replicon RNA Elicits Strong Immune Responses
Johansson Dx, Ljungberg K, Kakoulidou M, Liljestrom P
PLOS ONE 2012;7(1):e29732-

Superior Induction of T Cell Responses to Conserved HIV-1 Regions by Electroporated Alphavirus Replicon DNA Compared to That with Conventional Plasmid DNA Vaccine
Knudsen Ml, Mbewe-mvula A, Rosario M, Johansson Dx, Kakoulidou M, Bridgeman A, et al
JOURNAL OF VIROLOGY 2012;86(8):4082-90

Protective Efficacy of Serially Up-Ranked Subdominant CD8(+) T Cell Epitopes against Virus Challenges
Im Ej, Hong Jp, Roshorm Y, Bridgeman A, Letourneau S, Liljestrom P, et al
PLOS PATHOGENS 2011;7(5):e1002041-

Role of innate signalling pathways in the immunogenicity of alphaviral replicon-based vaccines
Naslund Ti, Kostic L, Nordstrom Ekl, Chen M, Liljestrom P
VIROLOGY JOURNAL 2011;:36-

Safety and immunogenicity of a modified pox vector-based HIV/AIDS vaccine candidate expressing Env, Gag, Pot and Nef proteins of HIV-1 subtype B (MVA-B) in healthy HIV-1-uninfected volunteers: A phase I clinical trial (RISVAC02)
Risvac-02 Study, Garcia F, De Quiros Jclb, Gomez Ce, Perdiguero B, Najera Jl, et al
VACCINE 2011;29(46):8309-16

Long peptides induce polyfunctional T cells against conserved regions of HIV-1 with superior breadth to single-gene vaccines in macaques
Rosario M, Bridgeman A, Quakkelaar Ed, Quigley Mf, Hill Bj, Knudsen Ml, et al
EUROPEAN JOURNAL OF IMMUNOLOGY 2010;40(7):1973-84

Comparison of Human and Rhesus Macaque T-Cell Responses Elicited by Boosting with NYVAC Encoding Human Immunodeficiency Virus Type 1 Clade C Immunogens
Mooij P, Balla-jhagjhoorsingh Ss, Beenhakker N, Van Haaften P, Baak I, Nieuwenhuis Ig, et al
JOURNAL OF VIROLOGY 2009;83(11):5881-9

Preclinical Evaluation of the Immunogenicity of C-Type HIV-1-Based DNA and NYVAC Vaccines in the Balb/C Mouse Model
Wild J, Bieler K, Kostler J, Frachette Mj, Jeffs S, Vieira S, et al
VIRAL IMMUNOLOGY 2009;22(5):309-19

An HIV-1 clade C DNA prime, NYVAC boost vaccine regimen induces reliable, polyfunctional, and long-lasting T cell responses
Harari A, Bart Pa, Stohr Wf, Tapia G, Garcia M, Medjitna-rais E, et al
JOURNAL OF EXPERIMENTAL MEDICINE 2008;205(1):63-77

EV01: A phase I trial in healthy HIV negative volunteers to evaluate a clade CHIV vaccine, NYVAC-C undertaken by the EuroVacc Consortium
Bart Pa, Goodall R, Barber T, Harari A, Guimaraes-walker A, Khonkarly M, et al
VACCINE 2008;26(25):3153-61

Comparative prime-boost vaccinations using Semliki Forest virus, adenovirus, and ALVAC vectors demonstrate differences in the generation of a protective central memory CTL response against the P815 tumor
Naslund Ti, Uyttenhove C, Nordstrom Ekl, Colau D, Warnier G, Jondal M, et al
JOURNAL OF IMMUNOLOGY 2007;178(11):6761-9

Generation and immunogenicity of novel HIV/AIDS vaccine candidates targeting HIV-1 Env/Gag-Pol-Nef antigens of clade C
Gomez Ce, Najera Jl, Jimenez V, Bieler K, Wild J, Kostic L, et al
VACCINE 2007;25(11):1969-92

Head-to-head comparison on the immunogenicity of two HIV/AIDS vaccine candidates based on the attenuated poxvirus strains MVA and NYVAC co-expressing in a single locus the HIV-1(BX08) gp120 and HIV-1(IIIB) Gag-Pol-Nef proteins of clade B
Gomez Ce, Najera Jl, Jimenez Ep, Jimenez V, Wagner R, Graf M, et al
VACCINE 2007;25(15):2863-85

Semliki forest virus nonstructural protein 2 is involved in suppression of the type I interferon response
Breakwell L, Dosenovic P, Hedestam Gbk, D'amato M, Liljestrom P, Fazakerley J, et al
JOURNAL OF VIROLOGY 2007;81(16):8677-84

Viral vectors for malaria vaccine development
Li Sq, Locke E, Bruder J, Clarke D, Doolan Dl, Havenga Mje, et al
VACCINE 2007;25(14):2567-74

Humoral responses against coimmunized protein antigen but not against alphavirus-encoded antigens require alpha/beta interferon signaling
Hidmark As, Nordstrom Ekl, Dosenovic P, Forsell Mne, Liljestrom P, Hedestam Gbk
JOURNAL OF VIROLOGY 2006;80(14):7100-10

Relation between viral fitness and immune escape within the hepatitis C virus protease
Soderholm J, Ahlen G, Kaul A, Frelin L, Alheim M, Barnfield C, et al
GUT 2006;55(2):266-74

RIG-I-mediated antiviral responses to single-stranded RNA bearing 5 '-phosphates
Pichlmair A, Schulz O, Tan Cp, Naslund Ti, Liljestrom P, Weber F, et al
SCIENCE 2006;314(5801):997-1001

Biochemical and immunogenic characterization of soluble human immunodeficiency virus type 1 envelope glycoprotein trimers expressed by Semliki Forest virus
Forsell Mne, Li Yx, Sundback M, Svehla K, Liljestrom P, Mascola Jr, et al
JOURNAL OF VIROLOGY 2005;79(17):10902-14

Early alpha/beta interferon production by myeloid dendritic cells in response to UV-inactivated virus requires viral entry and interferon regulatory factor 3 but not MyD88
Hidmark As, Mcinerney Gm, Nordstrom Ekl, Douagi I, Werner Km, Liljestrom P, et al
JOURNAL OF VIROLOGY 2005;79(16):10376-85

Efficient expansion of HIV-1-specific T cell responses by homologous immunization with recombinant Semliki Forest virus particles
Sundback M, Douagi I, Dayaraj C, Forsell Mne, Nordstrom Ekl, Mcinerney Gm, et al
VIROLOGY 2005;341(2):190-202

Enhanced immunogenicity using an alphavirus replicon DNA vaccine against human immunodeficiency virus type 1
Nordstrom Ekl, Forsell Mne, Barnfield C, Bonin E, Hanke T, Sundstrom M, et al
JOURNAL OF GENERAL VIROLOGY 2005;:349-54

Importance of eIF2 alpha phosphorylation assembly in alphavirus translation and stress granule regulation
Mcinerney Gm, Kedersha Nl, Kaufman Rj, Anderson P, Liljestrom P
MOLECULAR BIOLOGY OF THE CELL 2005;16(8):3753-63

Modulation of vaccine-induced immune responses to hepatitis C virus in rhesus macaques by altering priming before adenovirus boosting
Rollier C, Verschoor Ej, Paranhos-baccala G, Drexhage Jar, Verstrepen Be, Berland Jl, et al
JOURNAL OF INFECTIOUS DISEASES 2005;192(5):920-9

MyD88 expression is required for efficient cross-presentation of viral antigens from infected cells
Chen M, Barnfield C, Naslund Ti, Fleeton Mn, Liljestrom P
JOURNAL OF VIROLOGY 2005;79(5):2964-72

Reversible acid-induced inactivation of the membrane fusion protein of Semliki Forest virus
Waarts Bl, Smit Jm, Aneke Ojc, Mcinerney Gm, Liljestrom P, Bittman R, et al
JOURNAL OF VIROLOGY 2005;79(12):7942-8

Toll-like receptor 3 promotes cross-priming to virus-infected cells
Schulz O, Diebold Ss, Chen M, Naslund Ti, Nolte Ma, Alexopoulou L, et al
NATURE 2005;433(7028):887-92

Codon optimization and mRNA amplification effectively enhances the immunogenicity of the hepatitis C virus nonstructural 3/4A gene
Frelin L, Ahlen G, Alheim M, Weiland O, Barnfield C, Liljestrom P, et al
GENE THERAPY 2004;11(6):522-33

Delivery and expression of heterologous genes in mammalian cells using self-replicating alphavirus vectors
Karlsson Gb, Liljeström P
Methods in molecular biology (Clifton, N.J.) 2004;246():543-57

DNA immunization followed by a viral vector booster in a Chlamydia pneumoniae mouse model
Penttila T, Tammiruusu A, Liljestrom P, Sarvas M, Makela Ph, Vuola Jm, et al
VACCINE 2004;22(25-26):3386-94

HLA-A*0201 specific immunogenicity of modified vaccinia virus Ankara (MVA) produced hepatitis C virus antigens - Advantage of heterologous prime boost vaccination
Staib C, Meyr M, Barnfield C, Arribillaga L, Lasarte Jj, Erfle V, et al
HEPATOLOGY 2004;40(4):733A-733A

Immunization with PfEMP1-DBL1 alpha generates antibodies that disrupt rosettes and protect against the sequestration of Plasmodium falciparum-infected erythrocytes
Chen Qj, Pettersson F, Vogt Am, Schmidt B, Ahuja S, Liljestrom P, et al
VACCINE 2004;22(21-22):2701-12

Semliki Forest virus produced in the absence of the 6K protein has an altered spike structure as revealed by decreased membrane fusion capacity
Mcinerney Gm, Smit Jm, Liljestrom P, Wilschut J
VIROLOGY 2004;325(2):200-6

T-cell-mediated protective efficacy of a systemic vaccine approach in cynomolgus monkeys after SIV mucosal challenge
Michelini Z, Negri Drm, Baroncelli S, Catone S, Comini A, Maggiorella Mt, et al
JOURNAL OF MEDICAL PRIMATOLOGY 2004;33(5-6):251-61

Vaccine protection from CD4(+) T-cell loss caused by simian immunodeficiency virus (SIV) mac251 is afforded by sequential immunization with three unrelated vaccine vectors encoding multiple SIV antigens
Koopman G, Mortier D, Hofman S, Niphuis H, Fagrouch Z, Norley S, et al
JOURNAL OF GENERAL VIROLOGY 2004;:2915-24

Construction and immunogenicity in a prime-boost regimen of a Semliki Forest virus-vectored experimental HIV clade A vaccine
Hanke T, Barnfield C, Wee Egt, Agren L, Samuel Rv, Larke N, et al
JOURNAL OF GENERAL VIROLOGY 2003;:361-8

Live viral vectors: Semliki Forest virus
Karlsson Gb, Liljeström P
Methods in molecular medicine 2003;87():69-82

Low dose and gene gun immunization with a hepatitis C virus nonstructural (NS) 3 DNA-based vaccine containing NS4A inhibit NS3/4A-expressing tumors in vivo
Frelin L, Alheim M, Chen A, Soderholm J, Rozell B, Barnfield C, et al
GENE THERAPY 2003;10(8):686-99

Comparison of the efficacy of early versus late viral proteins in vaccination against SIV
Stittelaar Kj, Gruters Ra, Schutten M, Van Baalen Ca, Van Amerongen G, Cranage M, et al
VACCINE 2002;20(23-24):2921-7

Competition between CTL narrows the immune response induced by prime-boost vaccination protocols
Palmowski Mj, Choi Eml, Hermans If, Gilbert Sc, Chen Jl, Gileadi U, et al
JOURNAL OF IMMUNOLOGY 2002;168(9):4391-8

Hepatitis C virus non-structural protein 3-specific cellular immune responses following single or combined immunization with DNA or recombinant Semliki Forest virus particles
Brinster C, Chen M, Boucreux D, Paranhos-baccala G, Liljestrom P, Lemmonier F, et al
JOURNAL OF GENERAL VIROLOGY 2002;:369-81

Immunotherapy with recombinant SFV-replicons expressing the P815A tumor antigen or IL-12 induces tumor regression
Colmenero P, Chen M, Castanoz-velez E, Liljestrom P, Jondal M
INTERNATIONAL JOURNAL OF CANCER 2002;98(4):554-60

The chimeric combo vaccine strategy: a study evaluating immunogenicity and efficacy to protect against simian/human immunodeficiency virus infection in rhesus macaques.
Rosenwirth B, Oostermeijer H, Steeneveld E, Koornstra W, Ten Haaft P, Niphuis H, et al
ANTIVIRAL RESEARCH 2002;53(3):A47-A47

A recombinant Semliki Forest virus particle vaccine encoding the prME and NSl proteins of louping ill virus is effective in a sheep challenge model
Morris-downes Mm, Sheahan Bj, Fleeton Mn, Liljestrom P, Reid Hw, Atkins Gj
VACCINE 2001;19(28-29):3877-84

Comparative immunization study using RNA and DNA constructs encoding a part of the Plasmodium falciparum antigen Pf332
Andersson C, Vasconcelos Nm, Sievertzon M, Haddad D, Liljeqvist S, Berglund P, et al
SCANDINAVIAN JOURNAL OF IMMUNOLOGY 2001;54(1-2):117-24

Enhanced simian immunodeficiency virus-specific immune responses in macaques induced by priming with recombinant Semliki Forest virus and boosting with modified vaccinia virus Ankara
Nilsson C, Makitalo B, Berglund P, Bex F, Liljestrom P, Sutter G, et al
VACCINE 2001;19(25-26):3526-36

Expression of proteins using Semliki Forest virus vectors
Liljeström P, Garoff H
Current protocols in molecular biology 2001;Chapter 16():-

M-X-I motif of semliki forest virus capsid protein affects nucleocapsid assembly
Skoging-nyberg U, Liljestrom P
JOURNAL OF VIROLOGY 2001;75(10):4625-32

Recombinant Semliki Forest virus vaccine vectors: the route of injection determines the localization of vector RNA and subsequent T cell response
Colmenero P, Berglund P, Kambayashi T, Biberfeld P, Liljestrom P, Jondal M
GENE THERAPY 2001;8(17):1307-14

Self-replicative RNA vaccines elicit protection against influenza A virus, respiratory syncytial virus, and a tickborne encephalitis virus
Fleeton Mn, Chen M, Berglund P, Rhodes G, Parker Se, Murphy M, et al
JOURNAL OF INFECTIOUS DISEASES 2001;183(9):1395-8

Semliki Forest virus-based vaccines: persistence, distribution and pathological analysis in two animal systems
Morris-downes Mm, Phenix Kv, Smyth J, Sheahan Bj, Lileqvist S, Mooney Da, et al
VACCINE 2001;19(15-16):1978-88

A conserved leucine in the cytoplasmic domain of the Semliki Forest virus spike protein is important for budding
Skoging-nyberg U, Liljestrom P
ARCHIVES OF VIROLOGY 2000;145(6):1225-30

A vaccine strategy utilizing a combination of three different chimeric vectors which share specific vaccine antigens
Heeney Jl, Koopman G, Rosenwirth B, Bogers W, Van Dijk J, Nieuwenhuis I, et al
JOURNAL OF MEDICAL PRIMATOLOGY 2000;29(3-4):268-73

Cell culture evaluation of the Semliki Forest virus expression system as a novel approach for antigen delivery and expression in fish
Phenix Kv, Mckenna B, Fitzpatrick R, Vaughan L, Atkins G, Liljestrom P, et al
MARINE BIOTECHNOLOGY 2000;2(1):27-37

Protection against respiratory syncytial virus (RSV) elicited in mice by plasmid DNA immunisation encoding a secreted RSV G protein-derived antigen
Andersson C, Liljestrom P, Stahl S, Power Uf
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY 2000;29(4):247-53

Recombinant Semliki Forest virus particles expressing louping ill virus antigens induce a better protective response than plasmid-based DNA vaccines or an inactivated whole particle vaccine
Fleeton Mn, Liljestrom P, Sheahan Bj, Atkins Gj
JOURNAL OF GENERAL VIROLOGY 2000;:749-58

Use of conventional or replicating nucleic acid-based vaccines and recombinant Semliki Forest virus-derived particles for the induction of immune responses against hepatitis C virus core and E2 antigens
Vidalin O, Fournillier A, Renard N, Chen M, Depla E, Boucreux D, et al
VIROLOGY 2000;276(2):259-70

An anti-HIV strategy combining chemotherapy and therapeutic vaccination
Rosenwirth B, Bogers Wmjm, Nieuwenhuis Ig, Ten Haaft P, Niphuis H, Kuhn Em, et al
JOURNAL OF MEDICAL PRIMATOLOGY 1999;28(4-5):195-205

Immunization with recombinant Semliki Forest virus induces protection against influenza challenge in mice
Berglund P, Fleeton Mn, Smerdou C, Liljestrom P
VACCINE 1999;17(5):497-507

Induction of P815 tumor immunity by recombinant Semliki Forest virus expressing the P1A gene
Colmenero P, Liljestrom P, Jondal M
GENE THERAPY 1999;6(10):1728-33

Non-viral amplification systems for gene transfer: Vectors based on alphaviruses
Smerdou C, Liljestrom P
CURRENT OPINION IN MOLECULAR THERAPEUTICS 1999;1(2):244-51

Recombinant Semliki Forest virus particles encoding the prME or NS1 proteins of louping ill virus protect mice from lethal challenge
Fleeton Mn, Sheahan Bj, Gould Ea, Atkins Gj, Liljestrom P
JOURNAL OF GENERAL VIROLOGY 1999;:1189-98

The molecular pathogenesis of Semliki Forest virus: a model virus made useful?
Atkins Gj, Sheahan Bj, Liljestrom P
JOURNAL OF GENERAL VIROLOGY 1999;:2287-97

Two-helper RNA system for production of recombinant Semliki Forest virus particles
Smerdou C, Liljestrom P
JOURNAL OF VIROLOGY 1999;73(2):1092-8

Enhancing immune responses using suicidal DNA vaccines
Berglund P, Smerdou C, Fleeton Mn, Tubulekas I, Liljestrom P
NATURE BIOTECHNOLOGY 1998;16(6):562-5

Role of the C-terminal tryptophan residue for the structure-function of the alphavirus capsid protein
Skoging U, Liljestrom P
JOURNAL OF MOLECULAR BIOLOGY 1998;279(4):865-72

Suppressors of cleavage-site mutations in the p62 envelope protein of Semliki Forest virus reveal dynamics in spike structure and function
Tubulekas I, Liljestrom P
JOURNAL OF VIROLOGY 1998;72(4):2825-31

Alphavirus expression vectors and their use as recombinant vaccines: A minireview
Tubulekas I, Berglund P, Fleeton M, Liljestrom P
GENE 1997;190(1):191-5

Budding of enveloped viruses from the plasma membrane
Cadd Tl, Skoging U, Liljestrom P
BIOESSAYS 1997;19(11):993-1000

Cloning of human IL-12 p40 and p35 DNA into the Semliki Forest virus vector: Expression of IL-12 in human tumor cells
Zhang J, Asselinpaturel C, Bex F, Bernard J, Chehimi J, Willems F, et al
GENE THERAPY 1997;4(4):367-74

Eukaryotic expression vector systems: Biology and applications - Preface
Hasnain Se, Roy P, Liljestrom P
GENE 1997;190(1):1-1

Outcome of immunization of cynomolgus monkeys with recombinant Semliki Forest virus encoding human immunodeficiency virus type 1 envelope protein and challenge with a high dose of SHIV-4 virus
Berglund P, Quesadarolander M, Putkonen P, Biberfeld G, Thorstensson R, Liljestrom P
AIDS RESEARCH AND HUMAN RETROVIRUSES 1997;13(17):1487-95

Alphaviruses as vectors for gene delivery
Berglund P, Tubulekas I, Liljestrom P
TRENDS IN BIOTECHNOLOGY 1996;14(4):130-4

Aromatic interactions define the binding of the alphavirus spike to its nucleocapsid
Skoging U, Vihinen M, Nilsson L, Liljestrom P
STRUCTURE 1996;4(5):519-29

Manipulation of the Semliki Forest virus genome and its potential for vaccine construction
Atkins Gj, Sheahan Bj, Liljestrom P
MOLECULAR BIOTECHNOLOGY 1996;5(1):33-8

Protection against lethal simian immunodeficiency virus SIVsmmPBj14 disease by a recombinant semliki forest virus gp160 vaccine and by a gp120 subunit vaccine
Mossman Sp, Bex F, Berglund P, Arthos J, Oneil Sp, Riley D, et al
JOURNAL OF VIROLOGY 1996;70(3):1953-60

GENERATION OF CYTOTOXIC AND HUMORAL IMMUNE-RESPONSES BY NONREPLICATIVE RECOMBINANT SEMLIKI-FOREST-VIRUS
Zhou Xz, Berglund P, Zhao Hx, Liljestrom P, Jondal M
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 1995;92(7):3009-13

HIGH-LEVEL EXPRESSION OF G-PROTEIN-COUPLED RECEPTORS WITH THE AID OF THE SEMLIKI-FOREST-VIRUS EXPRESSION SYSTEM
Lundstrom K, Mills A, Allet E, Ceszkowski K, Agudo G, Chollet A, et al
JOURNAL OF RECEPTOR AND SIGNAL TRANSDUCTION RESEARCH 1995;15(1-4):23-32

THE 6-KILODALTON MEMBRANE-PROTEIN OF SEMLIKI FOREST VIRUS IS INVOLVED IN THE BUDDING PROCESS
Loewy A, Smyth J, Vonbonsdorff Ch, Liljestrom P, Schlesinger Mj
JOURNAL OF VIROLOGY 1995;69(1):469-75

THE TAX TRANSACTIVATION PROTEIN OF HUMAN T-CELL LEUKEMIA-VIRUS TYPE-I COLOCALIZES WITH NP-KAPPAB PROTEINS IN NUCLEAR-BODIES
Bex F, Mcdowall A, Liljestrom P, Burny A, Gaynor R
AIDS RESEARCH AND HUMAN RETROVIRUSES 1995;:S142-S142

Show all publications